JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diehl, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diehl, A. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 47, 30843-30846, November 20, 1998

MINIREVIEW
Roles of CCAAT/Enhancer-binding Proteins in Regulation of Liver Regenerative Growth*

Anna Mae DiehlDagger

From The Johns Hopkins University, Baltimore, Maryland 21205

    ABSTRACT
Top
Abstract
Introduction
References

The expressions and activities of several CCAAT/enhancer-binding proteins (C/EBP) isoforms fluctuate in the regenerating liver. The physiological implications of these variations in C/EBP function remain poorly characterized in the setting of regeneration. However, lessons learned in various hepatocyte cell lines and by studying primary hepatocytes from transgenic C/EBPalpha -deficient mice suggest that the C/EBP isoforms are likely to influence proliferation, differentiated gene expression, and survival in mature, adult hepatocytes. In addition, these factors are potentially important modulators of liver nonparenchymal cell genes, including those that encode matrix molecules and growth factors that are required for successful liver regeneration. The possibility that members of the C/EBP family of transcription factors actively participate in many aspects of the regenerative response to liver injury is strengthened by growing evidence that many hepatocyte mitogens and co-mitogens regulate C/EBP activity. Furthermore, the C/EBPs themselves appear to regulate the expression of some of these growth regulators.

    INTRODUCTION
Top
Abstract
Introduction
References

Liver regeneration is a complex physiological response to liver injury during which the surviving, mature hepatocytes and liver nonparenchymal cells proliferate to reconstitute the pre-morbid mass of the damaged organ. The liver is one of the few tissues in adult vertebrates that retains the capacity for regeneration. However, such compensatory hyperplasia requires careful orchestration to assure that vital liver-specific functions are preserved while hepatocytes, which generally do not proliferate in adult animals, replicate. The study of organisms that are as divergent as urodeles and humans has identified common, fundamental processes that are required for the regeneration of any tissue. This work indicates that regeneration occurs only if injury-related changes in the local extracellular environment motivate differentiated, but proliferation-competent, cells to reenter the cell cycle while the normal homeostatic mechanisms that couple cell cycle reentry to cell death are suspended (1-3). Although much has been learned about the mechanisms that regulate hepatic regeneration, many aspects of the process remain poorly understood.

    CCAAT/Enhancer-binding Proteins and Hepatocyte Proliferation

CCAAT/enhancer-binding proteins (C/EBPs)1 are known to play important roles in regulating the expression of multiple hepatocyte-specific genes (4). These transcription factors also help to control hepatocyte progression through the cell cycle (5, 6). Thus, the C/EBPs are likely to be important targets for regulation during liver regeneration. Consistent with this concept, variations in the expression of C/EBP mRNAs, proteins, and DNA binding activities have been documented during liver regeneration. C/EBPalpha is the predominant C/EBP isoform that is expressed by adult hepatocytes in healthy livers. During the initial 24 h after 70% (partial) hepatectomy (PH), levels of C/EBPalpha mRNA and protein decline transiently. This is associated with decreased binding activity of C/EBPalpha homodimers in gel mobility shift assays. Decreases in C/EBPalpha are preceded by the induction of other C/EBP isoforms. The level of C/EBPbeta and C/EBPdelta mRNAs, proteins, and DNA binding activities increases in the early pre-replicative period following PH and returns to base line as hepatocytes enter S phase (7-10).

The importance of these reciprocal variations in C/EBPalpha and other C/EBP isoforms in regulating hepatocyte proliferation during liver regeneration has been debated. Present controversy stems from an apparently poor correlation between the induction of C/EBPbeta DNA binding activity and hepatocyte proliferation in transgenic mice strains with disruption of certain cytokines or cytokine receptors. Mice homozygous for a deletion in the gene for the type 1 TNF receptor have extremely limited hepatocyte proliferation after PH and yet exhibit apparently normal induction of total C/EBP DNA binding activity during the early pre-replicative period (11). In contrast, transgenic mice lacking the gene for type 2 TNF receptors demonstrate normal hepatocyte proliferation after PH but decreased induction of C/EBPbeta DNA binding activity (12). Furthermore, liver regeneration is severely inhibited in IL-6-null mice, although these animals exhibit normal induction of C/EBPbeta mRNAs after PH (13). However, because C/EBP function is regulated, to a large extent, by post-transcriptional modifications of the C/EBPs themselves, as well as by their interactions with specific dimerization partners (14-21), the former observations do not preclude an important role for the C/EBPs as regulators of hepatocyte proliferation during liver regeneration. Indeed, other evidence supports the biological importance of the C/EBPs as physiologically relevant regulators of hepatocyte proliferation. Transgenic mice with a deleted C/EBPalpha gene have increased hepatocyte proliferation at birth (22, 23). Because these animals do not survive long enough to permit evaluation of their response to PH, whether or not C/EBPalpha deletion enhances hepatocyte proliferation during liver regeneration has not been tested. However, hepatocytes isolated from these mice do have increased proliferative activity in culture (24). Conversely, enforced overexpression of C/EBPalpha has been shown to inhibit proliferation in several different hepatocyte cell lines (5, 25, 26). Thus, it seems reasonable to conclude that changes in the relative amounts (or activities) of C/EBPalpha and other C/EBP isoforms influence the proliferative activity of hepatocytes during liver regeneration. However, because of the complexity of the C/EBP family of transcription factors, the multiple extracellular signals that regulate C/EBP activities, and the fact that hepatocytes co-express several different C/EBP isoforms, the role of each C/EBP family member in the regulation of hepatocyte proliferation during liver regeneration remains uncertain. Now that transgenic mice have been developed with targeted disruption of different C/EBP genes, it will be possible to use these mice to delineate the relative importance of different C/EBP isoforms as regulators of the hepatocyte proliferative response in vivo. Indeed, Greenbaum and colleagues have reported preliminary evidence that C/EBPbeta knock-out mice exhibit impaired hepatocyte proliferation and decreased liver regeneration after PH.2

There are several mechanisms by which the C/EBPs may regulate hepatocyte proliferation. C/EBPalpha is known to stabilize p21/WAF, a protein that inhibits transition from the pre-replicative (G1) period into S phase (5). Because induction of C/EBPbeta and C/EBPdelta during the early pre-replicative period may inhibit subsequent C/EBPalpha activity by repressing C/EBPalpha gene expression, reciprocal variations in C/EBP isoforms could release hepatocytes from C/EBPalpha -mediated cell cycle arrest. There is also some evidence that C/EBPbeta may positively regulate the expression of genes that promote cell cycle progression. For example, C/EBP consensus sequences have been identified in the regulatory regions of cyclin D2 (27) and cyclin A (28) and may also interact with the retinoblastoma protein (RB) (29).

In addition to promoting hepatocyte proliferation, changes in the relative expression of different C/EBP isoforms may affect global changes in hepatocyte gene expression that permit these cells to survive the "stress" of regeneration. For example, C/EBPbeta and -delta are important in modulating the expression of various acute phase response genes, including those such as inducible nitric oxide synthase (iNOS) (30-32), that are thought to protect hepatocytes from cytokine-mediated toxicity (33-37). The activity of iNOS and production of nitric oxide (NO) increase in hepatocytes in the mid-late pre-replicative period following PH (38-40). NO has diverse biological actions and has recently been shown to inhibit caspase 3 activation by TNFalpha (33, 41). Given the pivotal role that caspase 3 plays in apoptosis (42-44), C/EBPbeta -mediated induction of NO production may be one of the mechanisms that prevents injury-related cytokines from causing hepatocyte apoptosis in the regenerating liver. Preliminary experiments in iNOS-deficient transgenic mice support this view.3

Although liver regeneration imposes a tremendous drain on hepatocyte ATP stores, hepatocyte necrosis is not normally increased by PH. Changes in the expression of phosphoenolpyruvate carboxykinase, glycogen synthase, and many other genes that regulate hepatic metabolism occur quickly after PH (45-47). C/EBPbeta and -delta are important transcriptional regulators of many of the genes that are involved in metabolism (48-50). As such, these transcription factors modify hepatocyte substrate utilization to assure energy homeostasis during the period of intense proliferative activity. Because failure to meet the increased ATP requirements during regenerative growth could lead to hepatocyte ATP depletion and necrosis, successful regulation of C/EBP activity may be important for thwarting hepatocyte necrosis during the regenerative response to injury.

    C/EBPs and Liver Nonparenchymal Cells

Successful regeneration of the liver requires much more than the proliferation of hepatocytes. Cells that form supporting structures, such as bile ducts and blood vessels, must also replicate. In addition, new matrix must be deposited to provide a scaffolding for the "rebuilding" effort. Furthermore, evidence that hepatocyte proliferation is driven largely by factors that are produced within the regenerating liver implies that de novo synthesis of autocrine and paracrine growth regulatory factors must follow liver injury (2). The importance of the C/EBPs in regulating these aspects of the hepatic regenerative response has barely been evaluated.

Matrix Production

Workers in the field of hepatic fibrogenesis have long recognized that inflammation initiates fibrosis. The molecular basis for this observation is being discovered. Injury-related cytokines, such as TNFalpha and IL-6, and oxidant stress are known to induce several transcription factors, including C/EBPbeta , that activate transcription of the type I collagen gene in stellate cells (2). C/EBP sites have also been identified in the promoters of metalloproteinases (51). Thus, the C/EBPs are likely to regulate matrix production and remodeling by hepatic nonparenchymal cells during liver regeneration.

Production of Paracrine and Autocrine Growth Regulators

Hepatocyte Growth Factor (HGF)-- Stellate cells are also the principal source of the hepatocyte mitogen, HGF, in the regenerating liver (2). The regulatory regions of the HGF gene contain C/EBP consensus motifs (52), and recently, C/EBPbeta was shown to trans-activate HGF gene expression. Furthermore, recombinant TNFalpha induces a dose-dependent increase in IL-6 expression in primary stellate cell cultures. This is followed by increased C/EBPbeta DNA binding activity and induction of HGF mRNA expression.4 These observations suggest that the C/EBPs play a role in regulating the production of paracrine growth factors in the regenerating liver. Definitive proof of this concept awaits analysis of HGF gene induction in the liver remnants of C/EBPbeta knock-out mice that have been subjected to PH.

TNFalpha and TNF-regulated Cytokines-- Injury-related cytokines, particularly TNFalpha and IL-6, are now widely acknowledged to play pivotal parts in the initiation of hepatocyte proliferation after PH (11, 13, 54, 55), although the relative importance and precise roles of these factors during liver regeneration remain a topic of considerable debate. Binding sites for C/EBPbeta have been identified in the promoters of a large number of cytokine genes, including TNFalpha , IL-1, -6, and -8, and granulocyte colony-stimulating factor (56-59). Transfection studies with TNFalpha reporter gene constructs have demonstrated that C/EBPbeta is much more active than C/EBPalpha as an inducer of TNF gene transcription. Furthermore, C/EBPbeta and -delta are the predominate C/EBP isoforms in activated macrophages, which produce large amounts of TNF and TNF-inducible cytokines. Consistent with the concept that C/EBPbeta is important for TNF induction, inflammation-related increases in serum TNFalpha concentrations are blunted in C/EBPbeta -deficient transgenic mice. This observation suggests that decreased production of TNFalpha may contribute to the impaired liver regeneration that Greenbaum's group has noted in C/EBPbeta knock-out mice. Decreases in TNFalpha , in turn, would be expected to influence the relative abundance of C/EBP family members in the nuclei of hepatocytes and other TNF target cells because TNF or peptide ligands that specifically activate type 1 or type 2 TNF receptors induce an almost instantaneous redistribution of preformed C/EBPbeta and C/EBPdelta from the cytosol into the nucleus (18). Although C/EBPbeta was initially proposed as a potential mediator of the TNF-dependent induction of IL-6, which occurs after PH (11, 54), studies using mice homozygous for a deletion in the gene for C/EBPbeta demonstrate that C/EBPbeta is not essential for IL-6 induction because these mice actually develop increased circulating levels of IL-6 as they age (60). Given this, it is unlikely that decreased induction of IL-6 contributes to the impaired liver regeneration that Greenbaum's group has noted in the C/EBPbeta knock-out mice. Rather, these observations demonstrate that organisms have developed many mechanisms to preserve cytokine induction when any given cytokine-induced transcription factor becomes deficient. The latter may help to explain why IL-6 induction is not entirely abolished in transgenic TNF receptor type 1-null mice (11) or in rats that were pretreated with anti-TNF antibodies before PH (54). Similarly, because IL-6 induces C/EBPbeta and C/EBPbeta regulates the transcription of multiple cytokines, including TNFalpha , it is difficult to assure that IL-6 is the only cytokine that is deficient in transgenic mice in which the IL-6 gene has been disrupted experimentally.

    Regulation of C/EBP Activity during Liver Regeneration

C/EBP function is regulated at many levels, consistent with the growing body of evidence which suggests that these factors regulate critical events that are involved in cellular proliferation, differentiation, and survival. Several hormones (e.g. insulin, glucagon, epinephrine, norepinephrine, and corticosteroids) that increase in the blood after PH (2) are known to regulate either the expression or activity of various C/EBP isoforms. For example, insulin has been shown to alter the turnover of the 40-42 kDa C/EBPalpha proteins, accelerating their degradation (61). Cyclic AMP is known to increase transcription of C/EBPbeta and -delta (61-63). Hence, glucagon and epinephrine, which increase adenylyl cyclase activity and promote the accumulation of hepatic cAMP in the early pre-replicative period, are likely to play a role in the induction of these C/EBP isoforms after PH. The cAMP-dependent kinase, protein kinase A, has also been shown to influence the function of C/EBPbeta protein by phosphorylating Ser299 (21). Norepinephrine and other alpha -adrenergic agents that promote increases in intracellular calcium and activate calmodulin-sensitive kinases in the regenerating liver may also regulate C/EBPbeta because there is evidence that Cam kinase II phosphorylation of C/EBPbeta alters its DNA binding activity (20). Regenerative increases in circulating corticosteroids may contribute to increase the expression of C/EBPdelta mRNAs that have been observed in the regenerating liver (63).

Several hepatocyte mitogens that regulate the hepatocyte proliferative response during regeneration (including epidermal growth factor, transforming growth factor alpha , and HGF) may also influence C/EBP function. These growth factors activate receptor tyrosine kinases that couple to mitogen-activated kinases (64), which are known to phosphorylate C/EBPbeta (65). Injury-related cytokines are also likely to play important roles in regulating C/EBP function in the regenerating liver. For example, IL-6 and IL-1beta are well established inducers of C/EBPbeta and C/EBPdelta mRNA expression, respectively (53), whereas TNFalpha has been shown to increase the DNA binding activity of C/EBPbeta and C/EBPdelta by affecting the nuclear localization of these proteins (18). The latter appears to have physiological relevance for liver regeneration because pretreatment with anti-TNF antibodies inhibits the nuclear accumulation of these C/EBP isoforms and decreases their participation in DNA complex formation after PH (46).

Thus, many factors that regulate the proliferation and differentiated functions of hepatocytes during the regenerative response are also known to effect the biological activity of the C/EBPs. Given this and the fact that the C/EBPs regulate the proliferation and differentiation of many types of cells, these transcription factors are likely to be important downstream targets for growth factor-initiated signals that drive the regeneration of the liver after it has been injured (Fig. 1). Definitive proof of this concept as well as progress in delineating the relative importance of various C/EBP family members during liver regeneration is now possible by studying the regenerative response to PH in transgenic mice strains with targeted deletion(s) of specific C/EBP genes.


View larger version (30K):
[in this window]
[in a new window]
  		Fig. 1.   After PH, there is transient inhibition of C/EBPalpha activity and induction of C/EBPbeta and -delta activities. These reciprocal variations in C/EBP family members modulate gene expression in different liver cell populations. Some of the phenotypic consequences in hepatocytes and liver nonparenchymal cells (e.g. macrophages, endothelial cells, stellate cells, and cholangiocytes) are indicated.


    FOOTNOTES

* This minireview will be reprinted in the 1998 Minireview Compendium, which will be available in December, 1998. This is the fourth article of five in the "Biological Role of the Isoforms of C/EBP Minireview Series."

Dagger To whom correspondence should be addressed: 912 Ross Bldg., The Johns Hopkins University, 720 Rutland St., Baltimore, MD 21205. Tel.: 410-955-7316; Fax: 410-955-9677; E-mail: amdiehl{at}welchlink.welch.jhu.edu.

The abbreviations used are: C/EBP, CCAAT/enhancer-binding protein; PH, 70% (partial) hepatectomy; TNF, tumor necrosis factor; IL, interleukin; iNOS, inducible nitric oxide synthase; NO, nitric oxide; HGF, hepatocyte growth factor.

2 L. Greenbaum, FASEB Conference, Snomass, CO, July, 1998.

3 A. M. Diehl and R. Rai, unpublished data.

4 R. Rai, F. Anania, S. Q. Yang, H. Z. Lin, J. J. Potter, and A. M. Diehl, submitted for publication.

    REFERENCES
Top
Abstract
Introduction
References

  1. Brockes, J. P. (1997) Science 276, 81-87[Abstract/Free Full Text]
  2. Michalopoulos, G. K., and DeFrances, M. C. (1997) Science 276, 60-66[Abstract/Free Full Text]
  3. Stocum, D. L. (1997) Science 276, 15[CrossRef][Medline] [Order article via Infotrieve]
  4. Lekstrom-Himes, J., and Xanthopoulos, K. G. (1998) J. Biol. Chem. 273, 28545-28548[Abstract/Free Full Text]
  5. Hendricks-Taylor, L. R., and Darlington, G. J. (1995) Nucleic Acids Res. 23, 4726-4733[Abstract/Free Full Text]
  6. Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R., and Darlington, G. J. (1996) Genes Dev. 10, 804-815[Abstract/Free Full Text]
  7. Mischoulon, D., Rana, B., Bucher, N. L., and Farmer, S. R. (1992) Mol. Cell. Biol. 12, 2553-2560[Abstract/Free Full Text]
  8. Flodby, P., Antonson, P., Barlow, C., Blanck, A., Porsch-Hallstrom, I., and Xanthopoulos, K. G. (1993) Exp. Cell Res. 208, 248-256[CrossRef][Medline] [Order article via Infotrieve]
  9. Diehl, A. M., and Yang, S. Q. (1994) Hepatology 19, 447-456[CrossRef][Medline] [Order article via Infotrieve]
  10. Rana, B., Xie, Y., Mischoulon, D., Bucher, N. L. R., and Farmer, S. R. (1995) J. Biol. Chem. 270, 18123-18132[Abstract/Free Full Text]
  11. Yamada, Y., Kirillova, I., Peschon, J. J., and Fausto, N. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1441-1446[Abstract/Free Full Text]
  12. Yamada, Y., Webber, E. M., Kirillova, I., Peschon, J. J., and Fausto, N. (1998) Hepatology 28, 959-970[CrossRef][Medline] [Order article via Infotrieve]
  13. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., and Taub, R. (1996) Science 274, 1379-1383[Abstract/Free Full Text]
  14. Poli, V., Mancini, F. P., and Cortese, R. (1990) Cell 63, 643-653[CrossRef][Medline] [Order article via Infotrieve]
  15. Descombes, P., and Schibler, U. (1991) Cell 67, 569-579[CrossRef][Medline] [Order article via Infotrieve]
  16. LeClair, K. P., Blanar, M. A., and Sharp, P. A. (1992) Proc. Natl. Acad. Sci. U. S. A. 90, 4679-4683[Abstract/Free Full Text]
  17. Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., and Akira, S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10193-10197[Abstract/Free Full Text]
  18. Yin, M., Yang, S. Q., Lin, H. Z., Lane, M. D., Chatterjee, S., and Diehl, A. M. (1996) J. Biol. Chem. 271, 17974-17978[Abstract/Free Full Text]
  19. Wegner, M., Cao, Z., and Rosenfeld, M. G. (1992) Science 256, 370-373[Abstract/Free Full Text]
  20. Trautwein, C., Caelles, C., vander Geer, P., Hunter, T., Karin, M., and Chojkier, M. (1993) Nature 364, 544-547[CrossRef][Medline] [Order article via Infotrieve]
  21. Chinery, R., Brockman, J. A., Dransfield, D. T., and Coffey, R. J. (1997) J. Biol. Chem. 272, 30356-30361[Abstract/Free Full Text]
  22. Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. H., Abdelsayed, S. V., Wilde, M. D., Taylor, R., Wilson, D. R., and Darlington, G. J. (1995) Science 269, 1108-1112[Abstract/Free Full Text]
  23. Flodby, P., Barlow, C., Kylefjord, H., Ahrlund-Richter, L., and Xanthopoulos, K. G. (1996) J. Biol. Chem. 271, 24753-24760[Abstract/Free Full Text]
  24. Soriano, H. E., Kang, D. C., Finegold, M. J., Hicks, M. J., Wang, N. D., Harrison, W., and Darlington, G. J. (1998) Hepatology 27, 332-340[CrossRef][Medline] [Order article via Infotrieve]
  25. Diehl, A. M., Johns, D., Yang, S. Q., Lin, H. Z., Yin, M., and Lawrence, J. (1996) J. Biol. Chem. 271, 7343-7350[Abstract/Free Full Text]
  26. Watkins, P. J., Condreay, J. P., Huber, E., Jacombs, S. J., and Adams, D. J. (1996) Cancer Res. 56, 1063-1067[Abstract/Free Full Text]
  27. Jun, D. Y., Kim, M. K., Kim, I. G., and Kim, Y. H. (1997) Mol. Cells 7, 537-543[Medline] [Order article via Infotrieve]
  28. Kramer, A., Carstens, C. B., and Fahl, W. E. (1996) J. Biol. Chem. 271, 6579-6582[Abstract/Free Full Text]
  29. Chen, P.-L., Riley, D. J., Chen, Y., and Lee, W.-H. (1996) Genes Dev. 10, 2794-2804[Abstract/Free Full Text]
  30. Goldring, C. E. P., Reveneau, S., Algarte, M., and Jeannin, J.-F. (1996) Nucleic Acids Res. 24, 1682-1687[Abstract/Free Full Text]
  31. Kinugawa, K.-i., Shimizu, T., Yao, A., Kohmoto, S., Serizawa, T., and Takahashi, T. (1997) Circ. Res. 81, 911-921[Abstract/Free Full Text]
  32. Hecker, M., PreiB, C., and Schini-Kerth, V. B. (1997) Br. J. Pharmacol. 120, 1067-1074[CrossRef][Medline] [Order article via Infotrieve]
  33. Kim, Y. M., Talanian, R. V., and Billiar, T. R. (1997) J. Biol. Chem. 272, 31138-31148[Abstract/Free Full Text]
  34. Bohlinger, I., Leist, M., Barsig, J., Uhlig, S., Tiegs, G., and Wendel, A. (1995) Hepatology 22, 1829-1837[CrossRef][Medline] [Order article via Infotrieve]
  35. Bautista, A. P., and Spitzer, J. J. (1994) Am. J. Physiol. 29, G783-G788
  36. Harbrecht, B., Stadler, J., Demetris, A., Simmons, R., and Billiar, T. (1994) Am. J. Physiol. 266, G1004-G1010[Abstract/Free Full Text]
  37. Horie, Y., Wolf, R., and Granger, D. N. (1997) Am. J. Physiol. 273, G1007-G1013[Abstract/Free Full Text]
  38. Diaz-Guerra, M. J. M., Velasco, M., Martin-Sanz, P., and Bosca, L. (1997) Biochem. J. 326, 791-797
  39. Obolenskaya, M., Schulze-Specking, A., Plaumann, B., Freudenberg, N., and Decker, K. (1994) Biochem. Biophys. Res. Commun. 204, 1305-1311[CrossRef][Medline] [Order article via Infotrieve]
  40. Obolenskaya, M. Y., Vanin, A. F., Mordvintcex, P. Z., Mulsch, A., and Decker, K. (1994) Biochem. Biophys. Res. Commun. 202, 571-576[CrossRef][Medline] [Order article via Infotrieve]
  41. Dimmler, S., Rippmann, V., Weiland, U., Haendeler, J., and Zekher, A. M. (1997) Circ. Res. 81, 970-976[Abstract/Free Full Text]
  42. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al.. (1995) Nature 376, 37-43[CrossRef][Medline] [Order article via Infotrieve]
  43. Casciola-Rosen, L. A., Miller, D. K., Anhalt, G. J., and Rosen, A. (1994) J. Biol. Chem. 269, 30757-30760[Abstract/Free Full Text]
  44. Casciola-Rosen, L. A., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A. (1996) J. Exp. Med. 813, 1957-1964
  45. Mohn, K. L., Laz, T. M., Melby, A. E., and Taub, R. (1990) J. Biol. Chem. 265, 21914-21921[Abstract/Free Full Text]
  46. Diehl, A. M., Yang, S. Q., Yin, M., Lin, H. Z., Nelson, S., and Bagby, G. (1995) Hepatology 22, 252-261[CrossRef][Medline] [Order article via Infotrieve]
  47. Greenbaum, L. E., Cressman, D. E., Haber, B. A., and Taub, R. (1995) J. Clin. Invest. 96, 1351-1365
  48. Nishiyori, A., Tashiro, H., Kimura, A., Akagi, K., Yamamura, K., Mori, M., and Takiguchi, M. (1994) J. Biol. Chem. 269, 1323-1331[Abstract/Free Full Text]
  49. Patel, Y. M., Yun, J. S., Liu, J., McGrane, M. M., and Hanson, R. W. (1994) J. Biol. Chem. 269, 5619-5628[Abstract/Free Full Text]
  50. Trautwein, C., Rakemann, T., Pietrangelo, A., Plumpe, J., Montosi, G., and Manns, M. P. (1996) J. Biol. Chem. 271, 22262-22270[Abstract/Free Full Text]
  51. Doyle, G. A. R., Pierce, R. A., and Parks, W. C. (1997) J. Biol. Chem. 272, 11840-11849[Abstract/Free Full Text]
  52. Jiang, J. G., and Zarnegar, R. (1997) Mol. Cell. Biol. 17, 5758-5770[Abstract]
  53. Alam, T., An, M. R., and Papaconstantinou, J. (1992) J. Biol. Chem. 267, 5021-5024[Abstract/Free Full Text]
  54. Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J., and Diehl, A. M. (1992) Am. J. Physiol. 263, G579-G585[Abstract/Free Full Text]
  55. Diehl, A. M., Yin, M., Fleckenstein, J., Yang, S. Q., Lin, H. Z., Brenner, D. A., Westwick, J., Bagby, G., and Nelson, S. (1994) Am. J. Physiol. 267, G552-G561[Abstract/Free Full Text]
  56. Yan, S. F., Trittto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., May, L., and Stern, D. (1995) J. Biol. Chem. 270, 11463-11471[Abstract/Free Full Text]
  57. Zhang, Y., and Rom, W. N. (1993) Mol. Cell. Biol. 13, 3831-3837[Abstract/Free Full Text]
  58. Wedel, A., Sulski, G., and Zeigler-Heitbrock, H. W. (1996) Cytokine 8, 355-341
  59. Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., and Kishimoto, T. (1990) EMBO. J. 9, 1897-1906[Medline] [Order article via Infotrieve]
  60. Alonzi, T., Gorgori, G., Screpanti, I., Gulino, A., and Poli, V. (1997) Immunobiology 198, 144-156[Medline] [Order article via Infotrieve]
  61. MacDougald, O. A., Cornelius, P., Liu, R., and Lane, D. M. (1995) J. Biol. Chem. 270, 647-654[Abstract/Free Full Text]
  62. Niehof, M., Manns, M. P., and Trautwein, C. (1997) Mol. Cell. Biol. 17, 3600-3613[Abstract]
  63. MacDougald, O. A., Cornelius, P., Lin, F.-T., Chen, S. S., and Lane, M. D. (1994) J. Biol. Chem. 269, 19041-19047[Abstract/Free Full Text]
  64. Davis, R. J. (1995) Mol. Reprod. Dev. 42, 459-467[CrossRef][Medline] [Order article via Infotrieve]
  65. Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., and Akira, S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2207-2211[Abstract/Free Full Text]

Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. Li, P. Gade, S. C. Nallar, A. Raha, S. K. Roy, S. Karra, J. K. Reddy, S. P. Reddy, and D. V. Kalvakolanu
The Med1 Subunit of Transcriptional Mediator Plays a Central Role in Regulating CCAAT/Enhancer-binding Protein-{beta}-driven Transcription in Response to Interferon-{gamma}
J. Biol. Chem., May 9, 2008; 283(19): 13077 - 13086.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Boggs and D. Reisman
C/EBPbeta Participates in Regulating Transcription of the p53 Gene in Response to Mitogen Stimulation
J. Biol. Chem., March 16, 2007; 282(11): 7982 - 7990.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Wiper-Bergeron, H. A. Salem, J. J. Tomlinson, D. Wu, and R. J. G. Hache
Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPbeta by GCN5
PNAS, February 20, 2007; 104(8): 2703 - 2708.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. I. Cesena, J.-R. Cardinaux, R. Kwok, and J. Schwartz
CCAAT/Enhancer-binding Protein (C/EBP) beta Is Acetylated at Multiple Lysines: ACETYLATION OF C/EBPbeta AT LYSINE 39 MODULATES ITS ABILITY TO ACTIVATE TRANSCRIPTION
J. Biol. Chem., January 12, 2007; 282(2): 956 - 967.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Y. P. Turmelle, O. Shikapwashya, S. Tu, P. W. Hruz, Q. Yan, and D. A. Rudnick
Rosiglitazone inhibits mouse liver regeneration
FASEB J, December 1, 2006; 20(14): 2609 - 2611.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
M. Woltje, B. Tschoke, V. von Bulow, R. Westenfeld, B. Denecke, S. Graber, and W. Jahnen-Dechent
CCAAT enhancer binding protein beta and hepatocyte nuclear factor 3beta are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression.
J. Mol. Endocrinol., April 1, 2006; 36(2): 261 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
N. Teixido, M. Soler, N. Rivera, J. Bernues, and A. Meseguer
CCAAT/Enhancer Binding Protein-Mediated Role of Thyroid Hormone in the Developmental Expression of the Kidney Androgen-Regulated Protein Gene in Proximal Convoluted Tubules
Mol. Endocrinol., February 1, 2006; 20(2): 389 - 404.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. J. Lee and S. G. Kim
Role of p90 Ribosomal S6-Kinase-1 in Oltipraz-Induced Specific Phosphorylation of CCAAT/Enhancer Binding Protein-beta for GSTA2 Gene Transactivation
Mol. Pharmacol., January 1, 2006; 69(1): 385 - 396.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. P. Martinez-Jimenez, M. J. Gomez-Lechon, J. V. Castell, and R. Jover
Transcriptional Regulation of the Human Hepatic CYP3A4: Identification of a New Distal Enhancer Region Responsive to CCAAT/Enhancer-Binding Protein {beta} Isoforms (Liver Activating Protein and Liver Inhibitory Protein)
Mol. Pharmacol., June 1, 2005; 67(6): 2088 - 2101.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Meng, A. Raha, S. Roy, J. Hu, and D. V. Kalvakolanu
IFN-{gamma}-Stimulated Transcriptional Activation by IFN-{gamma}-Activated Transcriptional Element-Binding Factor 1 Occurs via an Inducible Interaction with CAAAT/Enhancer-Binding Protein-{beta}
J. Immunol., May 15, 2005; 174(10): 6203 - 6211.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. Didon, I. Qvarfordt, O. Andersson, M. Nord, and G. C. Riise
Decreased CCAAT/Enhancer Binding Protein Transcription Factor Activity in Chronic Bronchitis and COPD
Chest, April 1, 2005; 127(4): 1341 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Takeji, N. Kawada, T. Moriyama, K. Nagatoya, S. Oseto, S. Akira, M. Hori, E. Imai, and T. Miwa
CCAAT/Enhancer-Binding Protein {delta} Contributes to Myofibroblast Transdifferentiation and Renal Disease Progression
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2383 - 2390.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q.-S. Zhu, B. Qian, and D. Levy
CCAAT/Enhancer-binding Protein {alpha} (C/EBP{alpha}) Activates Transcription of the Human Microsomal Epoxide Hydrolase Gene (EPHX1) through the Interaction with DNA-bound NF-Y
J. Biol. Chem., July 16, 2004; 279(29): 29902 - 29910.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Cortes-Canteli, M. Wagner, W. Ansorge, and A. Perez-Castillo
Microarray Analysis Supports a Role for CCAAT/Enhancer-binding Protein-{beta} in Brain Injury
J. Biol. Chem., April 2, 2004; 279(14): 14409 - 14417.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. J. Cho and S. G. Kim
Oltipraz Inhibits 3-Methylcholanthrene Induction of CYP1A1 by CCAAT/Enhancer-binding Protein Activation
J. Biol. Chem., November 7, 2003; 278(45): 44103 - 44112.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. N. Cassel and M. Nord
C/EBP transcription factors in the lung epithelium
Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L773 - L781.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. A. Kovacs, M. Steinmann, P. J. Magistretti, O. Halfon, and J.-R. Cardinaux
CCAAT/Enhancer-binding Protein Family Members Recruit the Coactivator CREB-binding Protein and Trigger Its Phosphorylation
J. Biol. Chem., September 19, 2003; 278(38): 36959 - 36965.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. P. Pilipuk, M. D. Galigniana, and J. Schwartz
Subnuclear Localization of C/EBP{beta} Is Regulated by Growth Hormone and Dependent on MAPK
J. Biol. Chem., September 12, 2003; 278(37): 35668 - 35677.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. Ji, W. Chang, M. Centrella, and T. L. McCarthy
Activation Domains of CCAAT Enhancer Binding Protein {delta}: Regions Required for Native Activity and Prostaglandin E2-Dependent Transactivation of Insulin-Like Growth Factor I Gene Expression in Rat Osteoblasts
Mol. Endocrinol., September 1, 2003; 17(9): 1834 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Khanna-Gupta, T. Zibello, H. Sun, P. Gaines, and N. Berliner
Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBPalpha and C/EBPepsilon ) and CDP/cut in myeloid maturation-induced lactoferrin gene expression
Blood, May 1, 2003; 101(9): 3460 - 3468.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. L. Kagan, R. T. Henke, R. Cabal-Manzano, G. E. Stoica, Q. Nguyen, A. Wellstein, and A. T. Riegel
Complex Regulation of the Fibroblast Growth Factor-binding Protein in MDA- MB-468 Breast Cancer Cells by CCAAT/Enhancer-binding Protein {beta}
Cancer Res., April 1, 2003; 63(7): 1696 - 1705.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q.-Q. Tang, T. C. Otto, and M. D. Lane
CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis
PNAS, February 4, 2003; 100(3): 850 - 855.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
K. W. Kang, I. J. Cho, C. H. Lee, and S. G. Kim
Essential Role of Phosphatidylinositol 3-Kinase-Dependent CCAAT/Enhancer Binding Protein {beta} Activation in the Induction of Glutathione S-Transferase by Oltipraz
J Natl Cancer Inst, January 1, 2003; 95(1): 53 - 66.
[Abstract] [Full Text] [PDF]

Home page